Edward I Chan, MD
Family Practice · Alameda
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 27 years
- Graduated 1999
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: 059551 · Alameda Hospital · Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chan’s office at (510) 521-2300 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A74119 · Current
Licensed to practise in California · since 2001 · expires 2028-10-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alameda HospitalAlameda, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Alameda Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.12) · 119 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.45 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.3 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 210 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 532 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,887 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,916 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.37 (0.77 to 5.96) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.58 to 4.02) · 85 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,359 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 98 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -2.4 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3.6 · 242 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 244 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 40 cases | None | Jul 2023 – Jun 2025 |
What patients said (319 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$136,744
Medicare paid this office $136,744 for 395 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 199 | $34,462 | $109 |
| Short return visit (20+ min) | 278 | $27,428 | $64 |
| Sarscov2 vac 50 mcg/0.5ml im | 112 | $21,390 | $150 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 66 | $10,103 | $153 |
| Admn sarscov2 vacc 1 dose | 113 | $7,429 | $52 |
See all 14 services
| Return visit (30+ min) | 199 | $34,462 | $109 |
| Short return visit (20+ min) | 278 | $27,428 | $64 |
| Sarscov2 vac 50 mcg/0.5ml im | 112 | $21,390 | $150 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 66 | $10,103 | $153 |
| Admn sarscov2 vacc 1 dose | 113 | $7,429 | $52 |
| Influenza vaccine split virus, preservative free | 67 | $5,616 | $81 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 214 | $4,543 | $15 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 15 | $4,326 | $288 |
| Administration of influenza virus vaccine | 72 | $2,867 | $38 |
| New patient visit (45+ min) | 15 | $1,691 | $113 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 17 | $1,478 | $51 |
| Administration of pneumococcal vaccine | 16 | $612 | $38 |
| Hemoglobin a1c level | 43 | $496 | $9 |
| Automated urinalysis test | 13 | $35 | $2 |
Procedures Medicare counted
| Removal of nail tissue | 1-10 | None |
| Removal of skin lesions | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
395 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 14% · Women 46% · Also on Medicaid 15% · Health risk score 1.04. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 69% · Diabetes 22% · Chronic kidney disease 20% · Coronary heart disease 18% · Atrial fibrillation 17% · Depression 17% · Cancer 14% · Heart failure 12% · COPD 8% · Stroke 7% · Dementia 6%.
The office billed $493,760, Medicare allowed $176,706 and paid $136,744; for 1,917 services of 53 kinds; $33,104 of it was for drugs given in the office and $103,640 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 395 | 1,917 | 75 | 1.04 | $493,760 | $136,744 |
| 2023 | 385 | 1,228 | 74 | 1.00 | $332,160 | $96,742 |
| 2022 | 392 | 1,271 | 75 | 0.95 | $336,628 | $98,222 |
| 2021 | 337 | 995 | 75 | 1.07 | $298,829 | $75,363 |
| 2020 | 263 | 819 | 74 | 1.08 | $242,581 | $50,715 |
| 2019 | 274 | 918 | 74 | 1.05 | $285,823 | $60,194 |
| 2018 | 328 | 1,047 | 73 | 1.06 | $294,981 | $67,440 |
| 2017 | 290 | 976 | 73 | 0.94 | $236,010 | $56,696 |
| 2016 | 272 | 837 | 73 | 0.91 | $200,756 | $49,925 |
| 2015 | 262 | 961 | 73 | 0.86 | $208,576 | $61,795 |
| 2014 | 257 | 793 | 73 | 0.90 | $155,263 | $42,378 |
| 2013 | 280 | 924 | 73 | 0.98 | $136,470 | $44,251 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Short return visit (20+ min) | 271 | $29,884 | $67 |
| Return visit (30+ min) | 121 | $14,988 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 83 | $12,693 | $153 |
| Influenza vaccine split virus, preservative free | 94 | $6,892 | $72 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 26 | $5,026 | $193 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 16 | $4,507 | $282 |
| Sarscov2 vac 50 mcg/0.5ml im | 31 | $4,433 | $143 |
| Administration of influenza virus vaccine | 99 | $3,665 | $36 |
| Adm sarscv2 bvl 30mcg/.3ml a | 32 | $1,548 | $48 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,500 | $115 |
| Admn sarscov2 vacc 1 dose | 31 | $1,500 | $48 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 16 | $857 | $50 |
| Administration of pneumococcal vaccine | 17 | $617 | $36 |
| Hemoglobin a1c level | 33 | $457 | $10 |
| Automated urinalysis test | 18 | $42 | $2 |
2022: 14 services
| Short return visit (20+ min) | 260 | $29,498 | $73 |
| Return visit (30+ min) | 121 | $16,786 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 64 | $9,879 | $154 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 31 | $8,646 | $279 |
| Influenza vaccine split virus, preservative free | 110 | $7,732 | $68 |
| Administration of influenza virus vaccine | 118 | $4,365 | $36 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 21 | $4,105 | $195 |
| Adm sarscv2 bvl 30mcg/.3ml a | 60 | $2,869 | $48 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,912 | $83 |
| New patient visit (45+ min) | 12 | $1,550 | $129 |
| Administration of pneumococcal vaccine | 38 | $1,380 | $36 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $707 | $47 |
| Hemoglobin a1c level | 38 | $642 | $10 |
| Automated urinalysis test | 13 | $33 | $2 |
2021: 13 services
| Return visit (30+ min) | 177 | $31,087 | $102 |
| Short return visit (20+ min) | 177 | $15,827 | $69 |
| Influenza vaccine split virus, preservative free | 91 | $5,987 | $65 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $5,251 | $159 |
| New patient visit (45+ min) | 21 | $2,745 | $131 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 12 | $2,405 | $200 |
| Pneumococcal vaccine, 23-valent | 17 | $2,129 | $125 |
| Administration of influenza virus vaccine | 98 | $2,097 | $21 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,463 | $91 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,370 | $86 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 18 | $1,095 | $50 |
| Hemoglobin a1c level | 38 | $573 | $10 |
| Administration of pneumococcal vaccine | 17 | $359 | $21 |
2020: 10 services
| Return visit (30+ min) | 158 | $21,773 | $78 |
| Short return visit (20+ min) | 113 | $8,355 | $55 |
| Telephone medical discussion with physician, 21-30 minutes | 36 | $3,959 | $94 |
| Influenza vaccine split virus, preservative free | 59 | $3,726 | $60 |
| Pneumococcal vaccine, 23-valent | 19 | $2,231 | $117 |
| New patient visit (45+ min) | 14 | $1,498 | $107 |
| Administration of influenza virus vaccine | 63 | $1,396 | $21 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,150 | $61 |
| Administration of pneumococcal vaccine | 23 | $471 | $20 |
| Hemoglobin a1c level | 20 | $212 | $10 |
2019: 9 services
| Return visit (30+ min) | 179 | $33,144 | $85 |
| Short return visit (20+ min) | 129 | $10,252 | $57 |
| Influenza vaccine split virus, preservative free | 85 | $4,812 | $55 |
| Administration of influenza virus vaccine | 90 | $1,877 | $20 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,676 | $140 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $971 | $49 |
| New patient visit (45+ min) | 11 | $761 | $69 |
| Hemoglobin a1c level | 35 | $592 | $11 |
| Administration of pneumococcal vaccine | 16 | $323 | $20 |
2018: 12 services
| Return visit (30+ min) | 215 | $37,434 | $85 |
| Short return visit (20+ min) | 180 | $11,424 | $51 |
| Pneumococcal vaccine, 13-valent | 16 | $3,131 | $196 |
| Influenza vaccine split virus, preservative free | 50 | $2,611 | $52 |
| Pneumococcal vaccine, 23-valent | 19 | $2,112 | $106 |
| Administration of influenza virus vaccine | 79 | $2,074 | $25 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,936 | $138 |
| New patient visit (45+ min) | 14 | $1,311 | $94 |
| Administration of pneumococcal vaccine | 35 | $910 | $25 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $813 | $51 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 31 | $593 | $19 |
| Hemoglobin a1c level | 30 | $458 | $12 |
2017: 10 services
| Return visit (30+ min) | 158 | $26,477 | $76 |
| Short return visit (20+ min) | 185 | $13,952 | $53 |
| Administration of influenza virus vaccine | 84 | $2,706 | $31 |
| Influenza vaccine split virus, preservative free | 38 | $1,826 | $48 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,611 | $134 |
| Pneumococcal vaccine, 23-valent | 16 | $1,506 | $94 |
| New patient visit (45+ min) | 13 | $1,271 | $98 |
| Administration of pneumococcal vaccine | 25 | $778 | $31 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 41 | $765 | $19 |
| Hemoglobin a1c level | 34 | $561 | $13 |
2016: 12 services
| Return visit (30+ min) | 147 | $20,595 | $78 |
| Short return visit (20+ min) | 160 | $11,119 | $49 |
| Pneumococcal vaccine, 13-valent | 24 | $4,189 | $175 |
| Administration of influenza virus vaccine | 77 | $2,308 | $30 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,232 | $131 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 11 | $2,111 | $192 |
| New patient visit (45+ min) | 12 | $1,338 | $111 |
| Administration of pneumococcal vaccine | 30 | $900 | $30 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 48 | $842 | $18 |
| Influenza vaccine split virus, preservative free | 18 | $685 | $38 |
| Hemoglobin a1c level | 21 | $285 | $13 |
| Automated urinalysis test | 12 | $42 | $3 |
2015: 7 services
| Return visit (30+ min) | 133 | $21,145 | $79 |
| Pneumococcal vaccine, 13-valent | 96 | $15,782 | $164 |
| Short return visit (20+ min) | 171 | $13,040 | $55 |
| Administration of pneumococcal vaccine | 95 | $2,851 | $30 |
| Administration of influenza virus vaccine | 59 | $1,776 | $30 |
| New patient visit (45+ min) | 11 | $1,254 | $114 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 53 | $625 | $12 |
2014: 7 services
| Return visit (30+ min) | 120 | $18,231 | $80 |
| Short return visit (20+ min) | 179 | $15,569 | $53 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,802 | $129 |
| Administration of influenza virus vaccine | 42 | $1,174 | $27 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 34 | $413 | $12 |
| Urinalysis, manual test | 12 | $58 | $3 |
| Blood glucose (sugar) test performed by hand-held instrument | 16 | $57 | $3 |
2013: 8 services
| Return visit (30+ min) | 133 | $19,674 | $77 |
| Short return visit (20+ min) | 185 | $13,987 | $52 |
| Administration of influenza virus vaccine | 75 | $2,013 | $26 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,532 | $128 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 70 | $839 | $12 |
| Injection of drug or substance under skin or into muscle | 11 | $292 | $21 |
| Blood glucose (sugar) test performed by hand-held instrument | 26 | $107 | $3 |
| Urinalysis, manual test | 17 | $63 | $3 |
Medicaid work
$829 in 2023
Medicaid paid $829 for 27 billed services this clinician did in 2023, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 14 | $431 |
| Short return visit (20+ min) | 13 | $398 |
| 2023 | 27 | 2 | 14 | $829 |
| 2022 | 14 | 1 | 13 | $411 |
| 2018 | 13 | 1 | 12 | $409 |
See the largest Medicaid services in earlier years
2022
| Short return visit (20+ min) | 14 | $411 |
2018
| Short return visit (20+ min) | 13 | $409 |
Drugs they prescribed that Part D paid
$444,930
Pharmacies billed $444,930 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (81 of 3,801) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 17% of their opioid prescriptions.
3,364 generic and fewer than 11 brand-name prescriptions · $444,930 in drug cost · 67 antibiotic prescriptions to 40 people · 21 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 86 | $135,172 | $1,572 |
| Xarelto | 33 | $50,407 | $1,527 |
| Jardiance | 24 | $34,305 | $1,429 |
| Eliquis | 21 | $28,346 | $1,350 |
| Januvia | 11 | $17,767 | $1,615 |
See all 80 drugs
| Ozempic | 86 | $135,172 | $1,572 |
| Xarelto | 33 | $50,407 | $1,527 |
| Jardiance | 24 | $34,305 | $1,429 |
| Eliquis | 21 | $28,346 | $1,350 |
| Januvia | 11 | $17,767 | $1,615 |
| Cinacalcet | 11 | $14,209 | $1,292 |
| Trelegy Ellipta | 22 | $13,066 | $594 |
| Atorvastatin | 385 | $4,090 | $11 |
| Testosterone | 16 | $2,569 | $161 |
| Wixela Inhub | 14 | $2,104 | $150 |
| Lantus Solostar | 16 | $1,846 | $115 |
| Tamsulosin | 111 | $1,711 | $15 |
| Losartan | 184 | $1,496 | $8 |
| Albuterol Sulfate Hfa | 55 | $1,488 | $27 |
| Raloxifene | 25 | $1,329 | $53 |
| Gabapentin | 57 | $1,227 | $22 |
| Amlodipine Besylate | 156 | $1,142 | $7 |
| Hydrocodone-Acetaminophen | 32 | $1,084 | $34 |
| Metformin | 105 | $1,008 | $10 |
| Terazosin | 43 | $1,005 | $23 |
| Metoprolol | 58 | $950 | $16 |
| Valsartan | 13 | $839 | $65 |
| Rosuvastatin | 49 | $771 | $16 |
| Simvastatin | 102 | $769 | $8 |
| Pravastatin | 45 | $742 | $16 |
| Ezetimibe | 25 | $655 | $26 |
| Allopurinol | 36 | $605 | $17 |
| Montelukast | 36 | $590 | $16 |
| Lisinopril | 110 | $589 | $5 |
| Olmesartan Medoxomil | 28 | $584 | $21 |
| Potassium Chloride | 22 | $580 | $26 |
| Carvedilol | 42 | $517 | $12 |
| Alendronate | 58 | $509 | $9 |
| Donepezil | 41 | $496 | $12 |
| Hydrochlorothiazide | 139 | $457 | $3 |
| Levothyroxine | 52 | $454 | $9 |
| Sertraline | 60 | $444 | $7 |
| Atenolol | 22 | $430 | $20 |
| Omeprazole | 38 | $412 | $11 |
| Chlorthalidone | 15 | $410 | $27 |
| Celecoxib | 11 | $403 | $37 |
| Duloxetine | 15 | $395 | $26 |
| Triamcinolone Acetonide | 31 | $379 | $12 |
| Pregabalin | 22 | $373 | $17 |
| Lovastatin | 31 | $373 | $12 |
| Pantoprazole | 27 | $354 | $13 |
| Buspirone | 15 | $350 | $23 |
| Ramipril | 16 | $333 | $21 |
| Trazodone | 17 | $319 | $19 |
| Doxazosin Mesylate | 15 | $303 | $20 |
| Fenofibrate | 19 | $295 | $16 |
| Paroxetine | 11 | $251 | $23 |
| Fluticasone Propionate | 20 | $249 | $12 |
| Metformin Hcl Er | 18 | $238 | $13 |
| Furosemide | 46 | $232 | $5 |
| Lansoprazole | 15 | $230 | $15 |
| Lisinopril-Hydrochlorothiazide | 13 | $230 | $18 |
| Glipizide | 20 | $226 | $11 |
| Meloxicam | 13 | $220 | $17 |
| Zolpidem | 35 | $217 | $6 |
| Eszopiclone | 11 | $217 | $20 |
| Lorazepam | 39 | $212 | $5 |
| Tramadol | 20 | $203 | $10 |
| Finasteride | 26 | $197 | $8 |
| Citalopram Hbr | 20 | $195 | $10 |
| Metoprolol | 21 | $191 | $9 |
| Zolpidem Tartrate Er | 16 | $164 | $10 |
| Meclizine | 17 | $153 | $9 |
| Olanzapine | 12 | $139 | $12 |
| Cyclobenzaprine | 14 | $121 | $9 |
| Clopidogrel | 21 | $118 | $6 |
| Nystatin | 12 | $92 | $8 |
| Sildenafil Citrate | 17 | $91 | $5 |
| Alprazolam | 20 | $76 | $4 |
| Clonazepam | 12 | $63 | $5 |
| Lidocaine Hcl Viscous | 11 | $61 | $6 |
| Glipizide Er | 14 | $53 | $4 |
| Spironolactone | 12 | $52 | $4 |
| Doxycycline Hyclate | 17 | $37 | $2 |
| Prednisone | 13 | $27 | $2 |
Year by year
| 2024 | 3,801 | 555 | 2% (81) | None | $444,930 |
| 2023 | 2,999 | 525 | 4% (132) | 11% | $362,954 |
| 2022 | 2,572 | 398 | 3% (77) | 11% | $256,397 |
| 2021 | 3,813 | 417 | 3% (114) | 11% | $307,968 |
| 2020 | 3,730 | 389 | 4% (132) | 12% | $374,597 |
| 2019 | 3,451 | 369 | 3% (93) | 14% | $345,688 |
| 2018 | 3,134 | 359 | 3% (98) | 14% | $283,394 |
| 2017 | 2,902 | 353 | 3% (96) | 15% | $267,308 |
| 2016 | 2,710 | 363 | 3% (80) | 16% | $296,996 |
| 2015 | 2,647 | 315 | 3% (89) | None | $245,130 |
| 2014 | 2,935 | 354 | 3% (97) | 20% | $199,215 |
| 2013 | 3,080 | 343 | 3% (106) | None | $190,516 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 71 drugs
| Eliquis | 29 | $42,144 | $1,453 |
| Xarelto | 25 | $41,402 | $1,656 |
| Ozempic | 25 | $40,294 | $1,612 |
| Jardiance | 16 | $29,133 | $1,821 |
| Januvia | 16 | $27,162 | $1,698 |
| Cinacalcet | 12 | $17,662 | $1,472 |
| Lantus Solostar | 19 | $14,495 | $763 |
| Oxycontin | 14 | $7,493 | $535 |
| Testosterone | 18 | $5,478 | $304 |
| Flovent Hfa | 12 | $5,340 | $445 |
| Atorvastatin | 250 | $4,972 | $20 |
| Basaglar Kwikpen U-100 | 13 | $4,656 | $358 |
| Gabapentin | 48 | $2,561 | $53 |
| Losartan | 143 | $2,123 | $15 |
| Raloxifene | 22 | $1,994 | $91 |
| Terazosin | 45 | $1,892 | $42 |
| Tamsulosin | 85 | $1,731 | $20 |
| Albuterol Sulfate Hfa | 43 | $1,285 | $30 |
| Triamcinolone Acetonide | 31 | $1,186 | $38 |
| Valsartan | 12 | $1,146 | $95 |
| Amlodipine Besylate | 116 | $1,134 | $10 |
| Hydrocodone-Acetaminophen | 46 | $1,022 | $22 |
| Potassium Chloride | 22 | $981 | $45 |
| Lisinopril | 107 | $928 | $9 |
| Simvastatin | 82 | $898 | $11 |
| Pantoprazole | 21 | $880 | $42 |
| Levothyroxine | 58 | $859 | $15 |
| Pravastatin | 28 | $846 | $30 |
| Metformin | 73 | $817 | $11 |
| Duloxetine | 13 | $751 | $58 |
| Clopidogrel | 29 | $703 | $24 |
| Metoprolol | 36 | $684 | $19 |
| Rosuvastatin | 36 | $671 | $19 |
| Sertraline | 40 | $652 | $16 |
| Ezetimibe | 18 | $511 | $28 |
| Quetiapine | 15 | $481 | $32 |
| Famotidine | 13 | $447 | $34 |
| Allopurinol | 34 | $444 | $13 |
| Buspirone | 21 | $441 | $21 |
| Lovastatin | 21 | $401 | $19 |
| Zolpidem | 23 | $383 | $17 |
| Carvedilol | 31 | $382 | $12 |
| Eszopiclone | 11 | $380 | $35 |
| Finasteride | 23 | $361 | $16 |
| Atenolol | 21 | $339 | $16 |
| Montelukast | 11 | $334 | $30 |
| Hydrochlorothiazide | 106 | $332 | $3 |
| Trazodone | 15 | $329 | $22 |
| Lorazepam | 58 | $323 | $6 |
| Fluticasone Propionate | 11 | $306 | $28 |
| Alprazolam | 17 | $290 | $17 |
| Olmesartan Medoxomil | 20 | $284 | $14 |
| Fenofibrate | 14 | $267 | $19 |
| Donepezil | 22 | $261 | $12 |
| Oxycodone | 14 | $254 | $18 |
| Omeprazole | 19 | $253 | $13 |
| Paxlovid (Eua) | 24 | $250 | $10 |
| Metoprolol | 16 | $214 | $13 |
| Fluoxetine | 16 | $211 | $13 |
| Escitalopram | 18 | $206 | $11 |
| Ramipril | 15 | $199 | $13 |
| Spironolactone | 12 | $193 | $16 |
| Citalopram Hbr | 16 | $193 | $12 |
| Furosemide | 31 | $191 | $6 |
| Cyclobenzaprine | 14 | $141 | $10 |
| Alendronate | 11 | $140 | $13 |
| Glipizide | 17 | $136 | $8 |
| Metformin Hcl Er | 18 | $134 | $7 |
| Clonazepam | 11 | $94 | $9 |
| Tramadol | 33 | $65 | $2 |
| Sulfamethoxazole-Trimethoprim | 13 | $53 | $4 |
2022: 67 drugs
| Januvia | 15 | $24,162 | $1,611 |
| Jardiance | 13 | $23,037 | $1,772 |
| Eliquis | 17 | $16,856 | $992 |
| Xarelto | 12 | $16,189 | $1,349 |
| Lantus Solostar | 14 | $12,447 | $889 |
| Testosterone | 23 | $6,086 | $265 |
| Onglyza | 12 | $6,046 | $504 |
| Raloxifene | 48 | $5,831 | $121 |
| Oxycontin | 11 | $5,574 | $507 |
| Basaglar Kwikpen U-100 | 14 | $4,861 | $347 |
| Lantus | 14 | $3,862 | $276 |
| Atorvastatin | 219 | $2,788 | $13 |
| Rosuvastatin | 25 | $2,680 | $107 |
| Terazosin | 65 | $2,505 | $39 |
| Methylphenidate Er | 12 | $2,055 | $171 |
| Valsartan | 13 | $1,469 | $113 |
| Colchicine | 11 | $1,421 | $129 |
| Albuterol Sulfate Hfa | 31 | $1,239 | $40 |
| Losartan | 101 | $1,203 | $12 |
| Ezetimibe | 25 | $1,182 | $47 |
| Pravastatin | 43 | $1,181 | $27 |
| Hydrocodone-Acetaminophen | 47 | $973 | $21 |
| Triamcinolone Acetonide | 24 | $873 | $36 |
| Ondansetron | 11 | $826 | $75 |
| Gabapentin | 35 | $788 | $23 |
| Tamsulosin | 43 | $741 | $17 |
| Quetiapine | 12 | $710 | $59 |
| Amlodipine Besylate | 69 | $684 | $10 |
| Lisinopril | 102 | $644 | $6 |
| Alprazolam | 20 | $613 | $31 |
| Simvastatin | 57 | $611 | $11 |
| Bupropion Xl | 21 | $579 | $28 |
| Metformin | 62 | $536 | $9 |
| Diltiazem 24hr Er (Cd) | 12 | $529 | $44 |
| Levothyroxine | 45 | $517 | $11 |
| Chlorthalidone | 16 | $501 | $31 |
| Metoprolol | 18 | $480 | $27 |
| Allopurinol | 37 | $442 | $12 |
| Fluticasone Propionate | 15 | $365 | $24 |
| Lovastatin | 29 | $349 | $12 |
| Zolpidem | 40 | $320 | $8 |
| Glipizide | 30 | $308 | $10 |
| Hydroxyzine | 11 | $304 | $28 |
| Omeprazole | 22 | $264 | $12 |
| Donepezil | 21 | $263 | $13 |
| Celecoxib | 12 | $263 | $22 |
| Carvedilol | 19 | $254 | $13 |
| Atenolol | 21 | $251 | $12 |
| Hydrochlorothiazide | 67 | $240 | $4 |
| Sertraline | 26 | $232 | $9 |
| Lorazepam | 58 | $227 | $4 |
| Potassium Chloride | 14 | $214 | $15 |
| Metoprolol | 30 | $213 | $7 |
| Olmesartan Medoxomil | 12 | $211 | $18 |
| Trazodone | 24 | $205 | $9 |
| Eszopiclone | 13 | $195 | $15 |
| Montelukast | 14 | $175 | $13 |
| Finasteride | 12 | $168 | $14 |
| Metformin Hcl Er | 16 | $154 | $10 |
| Clopidogrel | 11 | $145 | $13 |
| Pantoprazole | 14 | $142 | $10 |
| Spironolactone | 13 | $140 | $11 |
| Escitalopram | 16 | $127 | $8 |
| Ramipril | 12 | $111 | $9 |
| Zolpidem Tartrate Er | 11 | $105 | $10 |
| Clonazepam | 14 | $93 | $7 |
| Furosemide | 26 | $87 | $3 |
2021: 79 drugs
| Januvia | 20 | $31,158 | $1,558 |
| Xarelto | 25 | $26,099 | $1,044 |
| Eliquis | 12 | $12,098 | $1,008 |
| Linzess | 12 | $10,344 | $862 |
| Raloxifene | 73 | $10,328 | $141 |
| Advair Diskus | 15 | $6,916 | $461 |
| Atorvastatin | 377 | $6,846 | $18 |
| Testosterone | 24 | $6,445 | $269 |
| Flovent Hfa | 12 | $5,649 | $471 |
| Bystolic | 12 | $4,787 | $399 |
| Shingrix | 19 | $3,550 | $187 |
| Terazosin | 105 | $3,499 | $33 |
| Valsartan | 19 | $2,422 | $127 |
| Colchicine | 12 | $2,204 | $184 |
| Ezetimibe | 37 | $2,201 | $59 |
| Losartan | 149 | $2,089 | $14 |
| Metoprolol | 68 | $2,064 | $30 |
| Levothyroxine | 76 | $1,976 | $26 |
| Gabapentin | 40 | $1,839 | $46 |
| Methylphenidate Er | 11 | $1,792 | $163 |
| Pravastatin | 77 | $1,517 | $20 |
| Amlodipine Besylate | 200 | $1,412 | $7 |
| Lisinopril | 175 | $1,348 | $8 |
| Albuterol Sulfate Hfa | 30 | $1,328 | $44 |
| Rosuvastatin | 31 | $1,304 | $42 |
| Ventolin Hfa | 20 | $1,190 | $60 |
| Tamsulosin | 53 | $1,158 | $22 |
| Isosorbide Dinitrate | 11 | $1,139 | $104 |
| Metformin | 112 | $1,036 | $9 |
| Simvastatin | 107 | $928 | $9 |
| Diltiazem 24hr Er (Cd) | 17 | $861 | $51 |
| Hydrocodone-Acetaminophen | 61 | $861 | $14 |
| Chlorthalidone | 24 | $812 | $34 |
| Allopurinol | 48 | $799 | $17 |
| Triamcinolone Acetonide | 27 | $761 | $28 |
| Olmesartan Medoxomil | 19 | $730 | $38 |
| Pioglitazone | 18 | $730 | $41 |
| Lovastatin | 45 | $651 | $14 |
| Losartan-Hydrochlorothiazide | 19 | $640 | $34 |
| Duloxetine | 14 | $590 | $42 |
| Sertraline | 30 | $576 | $19 |
| Famotidine | 16 | $562 | $35 |
| Fluticasone Propionate | 26 | $548 | $21 |
| Glipizide | 33 | $506 | $15 |
| Ramipril | 21 | $502 | $24 |
| Atenolol | 39 | $471 | $12 |
| Lorazepam | 54 | $449 | $8 |
| Hydrochlorothiazide | 134 | $448 | $3 |
| Montelukast | 33 | $444 | $13 |
| Donepezil | 23 | $400 | $17 |
| Omeprazole | 27 | $398 | $15 |
| Pantoprazole | 22 | $331 | $15 |
| Trazodone | 33 | $304 | $9 |
| Zolpidem Tartrate Er | 14 | $295 | $21 |
| Carvedilol | 21 | $288 | $14 |
| Alprazolam | 15 | $264 | $18 |
| Alendronate | 29 | $261 | $9 |
| Metoprolol | 31 | $251 | $8 |
| Quetiapine | 13 | $242 | $19 |
| Citalopram Hbr | 17 | $241 | $14 |
| Finasteride | 12 | $240 | $20 |
| Enalapril Maleate | 12 | $224 | $19 |
| Furosemide | 48 | $223 | $5 |
| Clopidogrel | 22 | $207 | $9 |
| Mirtazapine | 13 | $185 | $14 |
| Metformin Hcl Er | 20 | $184 | $9 |
| Escitalopram | 12 | $148 | $12 |
| Olanzapine | 12 | $141 | $12 |
| Clotrimazole | 11 | $131 | $12 |
| Lisinopril-Hydrochlorothiazide | 13 | $130 | $10 |
| Tramadol | 29 | $123 | $4 |
| Clonidine | 25 | $120 | $5 |
| Eszopiclone | 11 | $98 | $9 |
| Temazepam | 11 | $78 | $7 |
| Clonazepam | 12 | $71 | $6 |
| Zolpidem | 15 | $63 | $4 |
| Ondansetron | 11 | $49 | $4 |
| Diazepam | 11 | $49 | $4 |
| Meloxicam | 11 | $26 | $2 |
2020: 73 drugs
| Glumetza | 12 | $74,601 | $6,217 |
| Xarelto | 29 | $31,298 | $1,079 |
| Januvia | 13 | $17,477 | $1,344 |
| Lantus Solostar | 15 | $12,514 | $834 |
| Raloxifene | 66 | $10,058 | $152 |
| Jardiance | 13 | $8,949 | $688 |
| Bystolic | 18 | $8,161 | $453 |
| Atorvastatin | 366 | $7,643 | $21 |
| Testosterone | 18 | $7,396 | $411 |
| Shingrix | 39 | $6,781 | $174 |
| Terazosin | 129 | $3,526 | $27 |
| Omega-3 Acid Ethyl Esters | 13 | $3,336 | $257 |
| Colchicine | 12 | $2,642 | $220 |
| Albuterol Sulfate Hfa | 50 | $2,316 | $46 |
| Ezetimibe | 23 | $2,264 | $98 |
| Metoprolol | 62 | $2,253 | $36 |
| Losartan | 156 | $2,111 | $14 |
| Diltiazem 24hr Er (Cd) | 17 | $2,062 | $121 |
| Pravastatin | 95 | $2,043 | $22 |
| Levothyroxine | 68 | $1,799 | $26 |
| Methylphenidate Er | 11 | $1,792 | $163 |
| Lisinopril | 167 | $1,449 | $9 |
| Tamsulosin | 66 | $1,410 | $21 |
| Amlodipine Besylate | 180 | $1,172 | $7 |
| Olmesartan Medoxomil | 20 | $1,143 | $57 |
| Valsartan | 21 | $1,102 | $52 |
| Lovastatin | 51 | $989 | $19 |
| Metformin | 97 | $934 | $10 |
| Sertraline | 60 | $907 | $15 |
| Synthroid | 12 | $854 | $71 |
| Simvastatin | 110 | $850 | $8 |
| Proair Respiclick | 12 | $814 | $68 |
| Hydrocodone-Acetaminophen | 55 | $729 | $13 |
| Hydrochlorothiazide | 156 | $664 | $4 |
| Famotidine | 23 | $642 | $28 |
| Clopidogrel | 33 | $561 | $17 |
| Montelukast | 36 | $557 | $15 |
| Gabapentin | 32 | $553 | $17 |
| Gemfibrozil | 13 | $533 | $41 |
| Pioglitazone | 17 | $524 | $31 |
| Fluticasone Propionate | 31 | $509 | $16 |
| Levetiracetam | 11 | $498 | $45 |
| Atenolol | 42 | $488 | $12 |
| Rosuvastatin | 18 | $482 | $27 |
| Allopurinol | 35 | $461 | $13 |
| Triamcinolone Acetonide | 15 | $460 | $31 |
| Glipizide | 34 | $408 | $12 |
| Enalapril Maleate | 13 | $365 | $28 |
| Lorazepam | 63 | $363 | $6 |
| Pantoprazole | 18 | $357 | $20 |
| Latanoprost | 12 | $345 | $29 |
| Finasteride | 15 | $332 | $22 |
| Donepezil | 17 | $282 | $17 |
| Potassium Chloride | 11 | $250 | $23 |
| Furosemide | 46 | $246 | $5 |
| Trazodone | 33 | $217 | $7 |
| Alendronate | 23 | $210 | $9 |
| Zolpidem Tartrate Er | 11 | $209 | $19 |
| Metformin Hcl Er | 14 | $189 | $13 |
| Carvedilol | 16 | $188 | $12 |
| Metoprolol | 28 | $185 | $7 |
| Olanzapine | 14 | $175 | $13 |
| Omeprazole | 14 | $174 | $12 |
| Tramadol | 48 | $144 | $3 |
| Temazepam | 14 | $140 | $10 |
| Citalopram Hbr | 16 | $139 | $9 |
| Tizanidine | 14 | $124 | $9 |
| Lisinopril-Hydrochlorothiazide | 15 | $118 | $8 |
| Clonazepam | 17 | $89 | $5 |
| Alprazolam | 11 | $69 | $6 |
| Zolpidem | 12 | $68 | $6 |
| Diazepam | 18 | $26 | $1 |
| Clonidine | 11 | $7 | $1 |
2019: 72 drugs
| Xarelto | 27 | $23,589 | $874 |
| Levemir | 12 | $17,502 | $1,459 |
| Testosterone | 18 | $12,585 | $699 |
| Januvia | 11 | $11,732 | $1,067 |
| Raloxifene | 55 | $11,105 | $202 |
| Trulicity | 12 | $9,685 | $807 |
| Pradaxa | 13 | $9,220 | $709 |
| Lantus Solostar | 18 | $7,987 | $444 |
| Atorvastatin | 295 | $6,761 | $23 |
| Bystolic | 12 | $4,716 | $393 |
| Colchicine | 21 | $3,903 | $186 |
| Metoprolol | 81 | $2,992 | $37 |
| Pravastatin | 103 | $2,876 | $28 |
| Ezetimibe | 25 | $2,683 | $107 |
| Terazosin | 98 | $2,444 | $25 |
| Novolin R | 15 | $2,259 | $151 |
| Tamsulosin | 75 | $1,899 | $25 |
| Proair Hfa | 19 | $1,828 | $96 |
| Levothyroxine | 68 | $1,739 | $26 |
| Simvastatin | 125 | $1,597 | $13 |
| Lisinopril | 152 | $1,488 | $10 |
| Levetiracetam | 22 | $1,437 | $65 |
| Olmesartan Medoxomil | 15 | $1,413 | $94 |
| Losartan | 107 | $1,279 | $12 |
| Albuterol Sulfate Hfa | 20 | $1,063 | $53 |
| Metformin | 108 | $1,023 | $9 |
| Rosuvastatin | 14 | $979 | $70 |
| Amlodipine Besylate | 144 | $925 | $6 |
| Diltiazem 24hr Er (Cd) | 16 | $889 | $56 |
| Ventolin Hfa | 15 | $864 | $58 |
| Hydrochlorothiazide | 144 | $789 | $5 |
| Lovastatin | 40 | $787 | $20 |
| Pantoprazole | 18 | $668 | $37 |
| Gabapentin | 28 | $642 | $23 |
| Hydrocodone-Acetaminophen | 48 | $632 | $13 |
| Oxycodone-Acetaminophen | 12 | $588 | $49 |
| Insulin | 12 | $568 | $47 |
| Valsartan | 12 | $494 | $41 |
| Atenolol | 40 | $492 | $12 |
| Sertraline | 31 | $491 | $16 |
| Allopurinol | 29 | $470 | $16 |
| Clopidogrel | 31 | $469 | $15 |
| Montelukast | 19 | $455 | $24 |
| Glipizide | 32 | $380 | $12 |
| Furosemide | 48 | $345 | $7 |
| Trazodone | 31 | $329 | $11 |
| Potassium Chloride | 13 | $322 | $25 |
| Lorazepam | 38 | $318 | $8 |
| Clonazepam | 19 | $311 | $16 |
| Triamcinolone Acetonide | 21 | $309 | $15 |
| Famotidine | 18 | $293 | $16 |
| Losartan-Hydrochlorothiazide | 14 | $283 | $20 |
| Carvedilol | 29 | $270 | $9 |
| Metoprolol | 39 | $257 | $7 |
| Tramadol | 26 | $255 | $10 |
| Omeprazole | 16 | $230 | $14 |
| Bethanechol Chloride | 12 | $224 | $19 |
| Donepezil | 12 | $214 | $18 |
| Temazepam | 23 | $211 | $9 |
| Fluticasone Propionate | 18 | $179 | $10 |
| Lisinopril-Hydrochlorothiazide | 16 | $148 | $9 |
| Olanzapine | 11 | $139 | $13 |
| Spironolactone | 14 | $132 | $9 |
| Glimepiride | 12 | $130 | $11 |
| Alendronate | 15 | $126 | $8 |
| Escitalopram | 11 | $103 | $9 |
| Zolpidem | 15 | $85 | $6 |
| Citalopram Hbr | 14 | $80 | $6 |
| Glyburide | 15 | $71 | $5 |
| Lithium Carbonate | 12 | $67 | $6 |
| Clonidine | 11 | $44 | $4 |
| Diazepam | 13 | $17 | $1 |
2018: 71 drugs
| Januvia | 16 | $14,233 | $890 |
| Levemir | 13 | $13,065 | $1,005 |
| Pradaxa | 18 | $10,212 | $567 |
| Advair Diskus | 17 | $10,063 | $592 |
| Raloxifene | 46 | $9,816 | $213 |
| Xarelto | 11 | $9,182 | $835 |
| Eliquis | 12 | $5,892 | $491 |
| Bystolic | 19 | $5,178 | $273 |
| Atorvastatin | 186 | $4,315 | $23 |
| Ezetimibe | 19 | $3,766 | $198 |
| Pravastatin | 122 | $3,470 | $28 |
| Metoprolol | 73 | $3,094 | $42 |
| Donepezil | 17 | $2,812 | $165 |
| Proair Hfa | 36 | $2,307 | $64 |
| Tamsulosin | 59 | $1,912 | $32 |
| Olmesartan Medoxomil | 15 | $1,763 | $118 |
| Terazosin | 102 | $1,720 | $17 |
| Levothyroxine | 66 | $1,687 | $26 |
| Hydrocodone-Acetaminophen | 59 | $1,232 | $21 |
| Simvastatin | 139 | $1,024 | $7 |
| Ventolin Hfa | 17 | $994 | $58 |
| Metformin | 121 | $937 | $8 |
| Lisinopril | 113 | $896 | $8 |
| Chlorthalidone | 12 | $890 | $74 |
| Temazepam | 19 | $845 | $44 |
| Valsartan-Hydrochlorothiazide | 15 | $820 | $55 |
| Amlodipine Besylate | 121 | $759 | $6 |
| Losartan | 74 | $741 | $10 |
| Valsartan | 15 | $737 | $49 |
| Potassium Chloride | 20 | $682 | $34 |
| Hydrochlorothiazide | 116 | $669 | $6 |
| Synthroid | 14 | $659 | $47 |
| Proctosol-Hc | 12 | $638 | $53 |
| Finasteride | 21 | $634 | $30 |
| Triamcinolone Acetonide | 20 | $601 | $30 |
| Levetiracetam | 18 | $577 | $32 |
| Insulin | 17 | $539 | $32 |
| Omeprazole | 30 | $413 | $14 |
| Gabapentin | 26 | $406 | $16 |
| Duloxetine | 11 | $383 | $35 |
| Lovastatin | 23 | $342 | $15 |
| Pantoprazole | 18 | $327 | $18 |
| Pioglitazone | 11 | $299 | $27 |
| Atenolol | 45 | $297 | $7 |
| Gemfibrozil | 13 | $296 | $23 |
| Clonazepam | 15 | $253 | $17 |
| Zolpidem | 28 | $251 | $9 |
| Polyethylene Glycol 3350 | 13 | $242 | $19 |
| Furosemide | 51 | $242 | $5 |
| Montelukast | 17 | $234 | $14 |
| Warfarin | 13 | $233 | $18 |
| Lisinopril-Hydrochlorothiazide | 18 | $228 | $13 |
| Citalopram Hbr | 14 | $221 | $16 |
| Metoprolol | 35 | $219 | $6 |
| Clopidogrel | 16 | $215 | $13 |
| Glipizide | 20 | $214 | $11 |
| Losartan-Hydrochlorothiazide | 16 | $213 | $13 |
| Lorazepam | 30 | $210 | $7 |
| Sertraline | 26 | $167 | $6 |
| Trazodone | 20 | $166 | $8 |
| Carvedilol | 20 | $161 | $8 |
| Tramadol | 17 | $121 | $7 |
| Bethanechol Chloride | 12 | $114 | $9 |
| Quetiapine | 17 | $112 | $7 |
| Paroxetine | 13 | $101 | $8 |
| Fluticasone Propionate | 15 | $99 | $7 |
| Azithromycin | 11 | $68 | $6 |
| Alprazolam | 20 | $64 | $3 |
| Diazepam | 17 | $51 | $3 |
| Meloxicam | 13 | $28 | $2 |
| Lithium Carbonate | 12 | $23 | $2 |
2017: 67 drugs
| Androgel | 18 | $18,328 | $1,018 |
| Lyrica | 20 | $10,990 | $550 |
| Raloxifene | 47 | $8,453 | $180 |
| Advair Diskus | 12 | $8,236 | $686 |
| Levemir | 14 | $7,858 | $561 |
| Lantus Solostar | 11 | $5,705 | $519 |
| Lantus | 12 | $3,957 | $330 |
| Olmesartan Medoxomil | 13 | $3,892 | $299 |
| Proair Hfa | 43 | $3,101 | $72 |
| Atorvastatin | 96 | $2,250 | $23 |
| Pravastatin | 84 | $2,242 | $27 |
| Metoprolol | 56 | $2,194 | $39 |
| Fenofibrate | 14 | $1,830 | $131 |
| Levothyroxine | 59 | $1,829 | $31 |
| Terazosin | 84 | $1,482 | $18 |
| Diltiazem 24hr Er | 13 | $1,373 | $106 |
| Doxazosin Mesylate | 20 | $1,229 | $61 |
| Tamsulosin | 42 | $1,209 | $29 |
| Memantine | 12 | $995 | $83 |
| Simvastatin | 126 | $974 | $8 |
| Pioglitazone | 19 | $936 | $49 |
| Hydrocodone-Acetaminophen | 56 | $932 | $17 |
| Metformin | 94 | $932 | $10 |
| Valsartan-Hydrochlorothiazide | 12 | $827 | $69 |
| Lisinopril | 103 | $819 | $8 |
| Amlodipine Besylate | 126 | $792 | $6 |
| Valsartan | 20 | $737 | $37 |
| Losartan | 57 | $683 | $12 |
| Omeprazole | 33 | $615 | $19 |
| Hydrochlorothiazide | 117 | $584 | $5 |
| Lovastatin | 31 | $436 | $14 |
| Ramipril | 12 | $418 | $35 |
| Gabapentin | 29 | $417 | $14 |
| Glyburide | 14 | $413 | $30 |
| Insulin | 14 | $391 | $28 |
| Atenolol | 53 | $386 | $7 |
| Allopurinol | 14 | $384 | $27 |
| Finasteride | 11 | $381 | $35 |
| Zolpidem | 42 | $371 | $9 |
| Donepezil | 23 | $334 | $15 |
| Phenobarbital | 11 | $325 | $30 |
| Sertraline | 33 | $300 | $9 |
| Lorazepam | 29 | $271 | $9 |
| Gemfibrozil | 17 | $259 | $15 |
| Clopidogrel | 17 | $252 | $15 |
| Etodolac | 13 | $244 | $19 |
| Warfarin | 19 | $231 | $12 |
| Paroxetine | 23 | $227 | $10 |
| Trazodone | 22 | $206 | $9 |
| Fluoxetine | 11 | $202 | $18 |
| Escitalopram | 23 | $180 | $8 |
| Montelukast | 14 | $173 | $12 |
| Quetiapine | 23 | $160 | $7 |
| Bethanechol Chloride | 12 | $159 | $13 |
| Glipizide | 22 | $154 | $7 |
| Furosemide | 39 | $145 | $4 |
| Carvedilol | 16 | $134 | $8 |
| Pantoprazole | 14 | $128 | $9 |
| Cyclobenzaprine | 12 | $113 | $9 |
| Fluticasone Propionate | 13 | $109 | $8 |
| Metoprolol | 20 | $82 | $4 |
| Tramadol | 15 | $76 | $5 |
| Diazepam | 15 | $64 | $4 |
| Azithromycin | 11 | $59 | $5 |
| Lithium Carbonate | 12 | $58 | $5 |
| Alprazolam | 13 | $39 | $3 |
| Clonazepam | 11 | $37 | $3 |
2016: 64 drugs
| Januvia | 18 | $15,825 | $879 |
| Androgel | 17 | $13,650 | $803 |
| Raloxifene | 32 | $8,258 | $258 |
| Advair Diskus | 23 | $7,731 | $336 |
| Zetia | 15 | $5,094 | $340 |
| Lantus | 11 | $3,432 | $312 |
| Atorvastatin | 101 | $2,504 | $25 |
| Valsartan | 38 | $2,255 | $59 |
| Levothyroxine | 76 | $2,177 | $29 |
| Pravastatin | 69 | $1,957 | $28 |
| Proair Hfa | 30 | $1,932 | $64 |
| Metoprolol | 42 | $1,845 | $44 |
| Diltiazem 24hr Er | 21 | $1,666 | $79 |
| Duloxetine | 18 | $1,199 | $67 |
| Hydrocodone-Acetaminophen | 55 | $1,180 | $21 |
| Nifedipine Er | 16 | $1,068 | $67 |
| Tamsulosin | 25 | $1,016 | $41 |
| Omeprazole | 57 | $957 | $17 |
| Simvastatin | 105 | $948 | $9 |
| Amlodipine Besylate | 104 | $944 | $9 |
| Ramipril | 15 | $940 | $63 |
| Hydroxychloroquine Sulfate | 11 | $900 | $82 |
| Metformin | 76 | $883 | $12 |
| Pioglitazone | 20 | $834 | $42 |
| Lisinopril | 97 | $820 | $8 |
| Terazosin | 58 | $749 | $13 |
| Quetiapine | 21 | $639 | $30 |
| Glyburide | 17 | $587 | $35 |
| Ventolin Hfa | 11 | $574 | $52 |
| Hydrochlorothiazide | 110 | $568 | $5 |
| Lovastatin | 34 | $528 | $16 |
| Atenolol | 56 | $518 | $9 |
| Memantine | 16 | $482 | $30 |
| Gabapentin | 28 | $458 | $16 |
| Losartan | 38 | $434 | $11 |
| Lorazepam | 27 | $411 | $15 |
| Potassium Chloride | 12 | $373 | $31 |
| Warfarin | 36 | $323 | $9 |
| Zolpidem | 46 | $320 | $7 |
| Clopidogrel | 21 | $295 | $14 |
| Glyburide-Metformin | 13 | $295 | $23 |
| Donepezil | 27 | $288 | $11 |
| Allopurinol | 14 | $284 | $20 |
| Fluticasone Propionate | 13 | $262 | $20 |
| Metoprolol | 37 | $245 | $7 |
| Pantoprazole | 23 | $233 | $10 |
| Triamcinolone Acetonide | 12 | $225 | $19 |
| Mirtazapine | 16 | $210 | $13 |
| Paroxetine | 18 | $204 | $11 |
| Losartan-Hydrochlorothiazide | 14 | $197 | $14 |
| Sertraline | 33 | $196 | $6 |
| Baclofen | 14 | $190 | $14 |
| Alendronate | 25 | $179 | $7 |
| Fluoxetine | 11 | $177 | $16 |
| Bethanechol Chloride | 12 | $155 | $13 |
| Furosemide | 43 | $151 | $4 |
| Glipizide | 17 | $143 | $8 |
| Tramadol | 16 | $121 | $8 |
| Diazepam | 16 | $112 | $7 |
| Trazodone | 18 | $111 | $6 |
| Naproxen | 11 | $103 | $9 |
| Lithium Carbonate | 12 | $57 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $53 | $4 |
| Alprazolam | 11 | $22 | $2 |
2015: 65 drugs
| Januvia | 24 | $19,388 | $808 |
| Androgel | 18 | $12,769 | $709 |
| Raloxifene | 32 | $8,326 | $260 |
| Combivent Respimat | 17 | $6,278 | $369 |
| Valsartan | 36 | $4,505 | $125 |
| Vytorin | 14 | $4,475 | $320 |
| Benicar | 14 | $4,368 | $312 |
| Bystolic | 16 | $4,093 | $256 |
| Pradaxa | 12 | $3,770 | $314 |
| Advair Diskus | 13 | $3,683 | $283 |
| Lantus | 11 | $3,474 | $316 |
| Pravastatin | 65 | $2,699 | $42 |
| Proair Hfa | 32 | $1,998 | $62 |
| Levothyroxine | 80 | $1,892 | $24 |
| Fenofibrate | 13 | $1,835 | $141 |
| Atorvastatin | 73 | $1,710 | $23 |
| Metoprolol | 37 | $1,690 | $46 |
| Duloxetine | 19 | $1,367 | $72 |
| Diltiazem 24hr Er | 23 | $1,303 | $57 |
| Hydrocodone-Acetaminophen | 54 | $1,237 | $23 |
| Glyburide | 28 | $1,118 | $40 |
| Simvastatin | 113 | $1,117 | $10 |
| Tamsulosin | 16 | $1,086 | $68 |
| Pioglitazone | 28 | $1,027 | $37 |
| Metformin | 87 | $1,014 | $12 |
| Clopidogrel | 38 | $987 | $26 |
| Lisinopril | 98 | $930 | $9 |
| Chlorthalidone | 12 | $904 | $75 |
| Omeprazole | 61 | $865 | $14 |
| Amlodipine Besylate | 66 | $767 | $12 |
| Terazosin | 55 | $663 | $12 |
| Losartan | 46 | $644 | $14 |
| Gabapentin | 26 | $539 | $21 |
| Lovastatin | 39 | $494 | $13 |
| Quetiapine | 16 | $486 | $30 |
| Atenolol | 53 | $484 | $9 |
| Hydrochlorothiazide | 86 | $482 | $6 |
| Synthroid | 11 | $470 | $43 |
| Bethanechol Chloride | 12 | $440 | $37 |
| Clotrimazole | 11 | $367 | $33 |
| Zolpidem | 53 | $356 | $7 |
| Potassium Chloride | 11 | $350 | $32 |
| Fluticasone Propionate | 21 | $334 | $16 |
| Pantoprazole | 21 | $329 | $16 |
| Fluoxetine | 16 | $304 | $19 |
| Finasteride | 19 | $297 | $16 |
| Glyburide-Metformin | 14 | $295 | $21 |
| Hydroxyzine | 12 | $272 | $23 |
| Metoprolol | 29 | $271 | $9 |
| Warfarin | 22 | $256 | $12 |
| Lorazepam | 39 | $252 | $6 |
| Donepezil | 13 | $250 | $19 |
| Ramipril | 16 | $243 | $15 |
| Tramadol | 17 | $181 | $11 |
| Furosemide | 25 | $166 | $7 |
| Alendronate | 15 | $150 | $10 |
| Trazodone | 18 | $131 | $7 |
| Sertraline | 23 | $128 | $6 |
| Naproxen | 15 | $127 | $8 |
| Lithium Carbonate | 13 | $123 | $9 |
| Diazepam | 25 | $99 | $4 |
| Carvedilol | 11 | $95 | $9 |
| Glipizide | 12 | $85 | $7 |
| Naphazoline | 14 | $60 | $4 |
| Clonazepam | 13 | $60 | $5 |
2014: 83 drugs
| Januvia | 36 | $15,644 | $435 |
| Diovan | 39 | $11,417 | $293 |
| Pradaxa | 15 | $7,426 | $495 |
| Xarelto | 17 | $6,617 | $389 |
| Spiriva | 13 | $5,237 | $403 |
| Raloxifene | 13 | $5,122 | $394 |
| Zetia | 15 | $4,971 | $331 |
| Combivent Respimat | 17 | $4,696 | $276 |
| Vytorin | 20 | $4,547 | $227 |
| Bystolic | 21 | $3,245 | $155 |
| Benicar | 26 | $3,181 | $122 |
| Qvar | 14 | $2,907 | $208 |
| Valsartan | 11 | $2,481 | $226 |
| Atorvastatin | 83 | $2,355 | $28 |
| Donepezil | 28 | $2,290 | $82 |
| Metoprolol | 38 | $2,281 | $60 |
| Pioglitazone | 22 | $2,084 | $95 |
| Fenofibrate | 15 | $2,058 | $137 |
| Pravastatin | 54 | $1,764 | $33 |
| Glyburide | 43 | $1,489 | $35 |
| Levothyroxine | 71 | $1,391 | $20 |
| Proair Hfa | 24 | $1,263 | $53 |
| Olanzapine | 17 | $1,210 | $71 |
| Simvastatin | 107 | $1,148 | $11 |
| Metformin | 90 | $1,090 | $12 |
| Valsartan-Hydrochlorothiazide | 17 | $976 | $57 |
| Diltiazem 24hr Er | 20 | $954 | $48 |
| Venlafaxine Hcl Er | 20 | $948 | $47 |
| Lisinopril | 101 | $924 | $9 |
| Atenolol | 110 | $855 | $8 |
| Hydrocodone-Acetaminophen | 53 | $852 | $16 |
| Doxazosin Mesylate | 29 | $821 | $28 |
| Losartan | 50 | $818 | $16 |
| Gabapentin | 29 | $798 | $28 |
| Clopidogrel | 24 | $786 | $33 |
| Nifedipine Er | 11 | $771 | $70 |
| Omeprazole | 54 | $715 | $13 |
| Lovastatin | 48 | $704 | $15 |
| Amlodipine Besylate | 71 | $686 | $10 |
| Lansoprazole | 13 | $662 | $51 |
| Terazosin | 42 | $623 | $15 |
| Chlorthalidone | 19 | $601 | $32 |
| Potassium Chloride | 16 | $573 | $36 |
| Hydrochlorothiazide | 87 | $456 | $5 |
| Triamcinolone Acetonide | 23 | $432 | $19 |
| Hydroxyzine | 35 | $431 | $12 |
| Escitalopram | 13 | $407 | $31 |
| Etodolac | 11 | $380 | $35 |
| Fluoxetine | 12 | $372 | $31 |
| Zolpidem | 52 | $356 | $7 |
| Fluticasone Propionate | 20 | $340 | $17 |
| Ramipril | 26 | $336 | $13 |
| Warfarin | 22 | $333 | $15 |
| Bethanechol Chloride | 12 | $301 | $25 |
| Glyburide-Metformin | 19 | $297 | $16 |
| Finasteride | 19 | $296 | $16 |
| Lorazepam | 29 | $291 | $10 |
| Verapamil Er | 14 | $273 | $20 |
| Losartan-Hydrochlorothiazide | 12 | $251 | $21 |
| Carvedilol | 21 | $247 | $12 |
| Quetiapine | 11 | $218 | $20 |
| Nortriptyline | 15 | $212 | $14 |
| Furosemide | 38 | $204 | $5 |
| Metoprolol | 29 | $185 | $6 |
| Lisinopril-Hydrochlorothiazide | 14 | $182 | $13 |
| Spironolactone | 14 | $179 | $13 |
| Tramadol | 25 | $172 | $7 |
| Famotidine | 22 | $171 | $8 |
| Ranitidine | 13 | $162 | $12 |
| Risperidone | 14 | $160 | $11 |
| Ibuprofen | 21 | $160 | $8 |
| Alendronate | 17 | $157 | $9 |
| Glipizide | 16 | $156 | $10 |
| Diazepam | 26 | $152 | $6 |
| Pantoprazole | 11 | $149 | $14 |
| Sertraline | 17 | $126 | $7 |
| Mirtazapine | 14 | $119 | $8 |
| Naproxen | 14 | $113 | $8 |
| Citalopram Hbr | 18 | $106 | $6 |
| Lithium Carbonate | 13 | $90 | $7 |
| Sulfamethoxazole-Trimethoprim | 14 | $83 | $6 |
| Trazodone | 13 | $51 | $4 |
| Alprazolam | 12 | $35 | $3 |
2013: 75 drugs
| Diovan | 71 | $14,055 | $198 |
| Januvia | 33 | $12,142 | $368 |
| Pioglitazone | 36 | $7,402 | $206 |
| Evista | 12 | $4,184 | $349 |
| Spiriva | 12 | $3,762 | $314 |
| Vytorin | 23 | $3,720 | $162 |
| Pradaxa | 13 | $3,579 | $275 |
| Vesicare | 12 | $3,295 | $275 |
| Zetia | 19 | $3,064 | $161 |
| Metoprolol | 39 | $3,009 | $77 |
| Atorvastatin | 72 | $2,634 | $37 |
| Bystolic | 14 | $2,537 | $181 |
| Valsartan-Hydrochlorothiazide | 15 | $2,426 | $162 |
| Fenofibrate | 11 | $2,244 | $204 |
| Benicar | 19 | $2,220 | $117 |
| Simvastatin | 155 | $1,796 | $12 |
| Pravastatin | 87 | $1,654 | $19 |
| Lansoprazole | 16 | $1,650 | $103 |
| Proair Hfa | 25 | $1,415 | $57 |
| Losartan | 66 | $1,373 | $21 |
| Omeprazole | 56 | $1,340 | $24 |
| Metformin | 91 | $1,324 | $15 |
| Novolin N | 15 | $1,247 | $83 |
| Lisinopril | 133 | $1,222 | $9 |
| Lovastatin | 65 | $1,038 | $16 |
| Atenolol | 112 | $1,006 | $9 |
| Venlafaxine Hcl Er | 23 | $977 | $42 |
| Diltiazem 24hr Er | 15 | $821 | $55 |
| Glyburide | 27 | $774 | $29 |
| Amlodipine Besylate | 67 | $771 | $12 |
| Terazosin | 53 | $767 | $14 |
| Hydrochlorothiazide | 132 | $736 | $6 |
| Levothyroxine | 48 | $701 | $15 |
| Hydrocodone-Acetaminophen | 63 | $676 | $11 |
| Pantoprazole | 27 | $627 | $23 |
| Verapamil Er | 16 | $536 | $34 |
| Alendronate | 34 | $508 | $15 |
| Chlorthalidone | 22 | $476 | $22 |
| Fluoxetine | 24 | $457 | $19 |
| Clopidogrel | 11 | $444 | $40 |
| Zolpidem | 66 | $403 | $6 |
| Finasteride | 15 | $387 | $26 |
| Tamsulosin | 12 | $373 | $31 |
| Warfarin | 18 | $366 | $20 |
| Fluticasone Propionate | 12 | $366 | $30 |
| Gabapentin | 25 | $348 | $14 |
| Donepezil | 22 | $336 | $15 |
| Carvedilol | 26 | $329 | $13 |
| Lisinopril-Hydrochlorothiazide | 26 | $316 | $12 |
| Triamcinolone Acetonide | 16 | $303 | $19 |
| Ramipril | 19 | $302 | $16 |
| Hydroxyzine | 21 | $291 | $14 |
| Doxazosin Mesylate | 14 | $278 | $20 |
| Indomethacin | 14 | $232 | $17 |
| Furosemide | 44 | $216 | $5 |
| Nortriptyline | 15 | $215 | $14 |
| Tramadol | 29 | $200 | $7 |
| Spironolactone | 16 | $195 | $12 |
| Glipizide | 16 | $194 | $12 |
| Lorazepam | 21 | $160 | $8 |
| Ranitidine | 14 | $157 | $11 |
| Enalapril Maleate | 16 | $153 | $10 |
| Benazepril | 18 | $147 | $8 |
| Metoprolol | 21 | $147 | $7 |
| Citalopram Hbr | 22 | $145 | $7 |
| Allopurinol | 20 | $145 | $7 |
| Azithromycin | 13 | $142 | $11 |
| Clonazepam | 15 | $127 | $8 |
| Cephalexin | 11 | $121 | $11 |
| Metformin Hcl Er | 11 | $119 | $11 |
| Bethanechol Chloride | 12 | $113 | $9 |
| Cyclobenzaprine | 11 | $113 | $10 |
| Lithium Carbonate | 12 | $108 | $9 |
| Sulfamethoxazole-Trimethoprim | 15 | $75 | $5 |
| Sertraline | 11 | $47 | $4 |
Money from drug and device companies
$218 in 2025
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $218 | 13 payments
|
See all 13 published payments
| Novo Nordisk | Meals · 2025-12-02 | None | $7 |
| Novo Nordisk | Meals · 2025-10-29 | Ozempic | $8 |
| Novo Nordisk | Meals · 2025-10-21 | None | $9 |
| Novo Nordisk | Meals · 2025-09-30 | Wegovy | $7 |
| Novo Nordisk | Meals · 2025-09-30 | Ozempic | $119 |
| Novo Nordisk | Meals · 2025-09-29 | None | $15 |
| Novo Nordisk | Meals · 2025-09-09 | None | $13 |
| Novo Nordisk | Meals · 2025-08-19 | None | $13 |
| Novo Nordisk | Meals · 2025-07-29 | None | $8 |
| Novo Nordisk | Meals · 2025-06-10 | None | $8 |
| Novo Nordisk | Meals · 2025-05-20 | None | $3 |
| Novo Nordisk | Meals · 2025-04-15 | None | $4 |
| Novo Nordisk | Meals · 2025-02-26 | None | $4 |
Professional record
- NPI
- 1366425548
- Licence
- CA A74119California A74119: Current · expires 2028-10-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A741190
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 2433 Central Ave, Ste A, Alameda, CA, 94501
- NPI first listed
- 2005-11-22
- NPI last updated
- 2023-03-07
This is when the NPI record was last certified, not a medical board exam.